Search Results - Kremers, Stephan

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomi... by Mai, Elias K. (Author) , Goldschmidt, Hartmut (Author) , Miah, Kaya (Author) , Bertsch, Uta (Author) , Besemer, Britta (Author) , Hänel, Mathias (Author) , Krzykalla, Julia (Author) , Fenk, Roland (Author) , Schlenzka, Jana (Author) , Munder, Markus (Author) , Dürig, Jan (Author) , Blau, Igor W (Author) , Huhn, Stefanie (Author) , Hose, Dirk (Author) , Jauch, Anna (Author) , Kunz, Christina (Author) , Mann, Christoph (Author) , Weinhold, Niels (Author) , Scheid, Christof (Author) , Schroers, Roland (Author) , von Metzler, Ivana (Author) , Schieferdecker, Aneta (Author) , Thomalla, Jörg (Author) , Reimer, Peter (Author) , Mahlberg, Rolf (Author) , Graeven, Ullrich (Author) , Kremers, Stephan (Author) , Martens, Uwe M (Author) , Kunz, Christian (Author) , Hensel, Manfred (Author) , Benner, Axel (Author) , Seidel-Glätzer, Andrea (Author) , Weisel, Katja C (Author) , Raab, Marc-Steffen (Author) , Salwender, Hans (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 2... by Heudobler, Daniel (Author) , Luke, Florian (Author) , Hahn, Joachim (Author) , Grube, Matthias (Author) , Schlosser, Pavla (Author) , Kremers, Stephan (Author) , Sudhoff, Thomas (Author) , Westermann, Jorg (Author) , Hutter-Kronke, Marie Luise (Author) , Schlenk, Richard Friedrich (Author) , Weber, Daniela (Author) , Paschka, Peter (Author) , Zeman, Florian (Author) , Dohner, Hartmut (Author) , Herr, Wolfgang (Author) , Reichle, Albrecht (Author) , Thomas, Simone (Author) ,


    Get full text
    Article (Journal) Editorial Online Resource
  3. 3

    CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study by Kriegsmann, Katharina (Author) , Ton, Gigi Nu Hoang Quy (Author) , Awwad, Mohamed (Author) , Benner, Axel (Author) , Bertsch, Uta (Author) , Besemer, Britta (Author) , Hänel, Mathias (Author) , Fenk, Roland (Author) , Munder, Markus (Author) , Dürig, Jan (Author) , Blau, Igor W. (Author) , Huhn, Stefanie (Author) , Hose, Dirk (Author) , Jauch, Anna (Author) , Mann, Christoph (Author) , Weinhold, Niels (Author) , Scheid, Christof (Author) , Schroers, Roland (Author) , von Metzler, Ivana (Author) , Schieferdecker, Aneta (Author) , Thomalla, Jörg (Author) , Reimer, Peter (Author) , Mahlberg, Rolf (Author) , Graeven, Ullrich (Author) , Kremers, Stephan (Author) , Martens, Uwe M. (Author) , Kunz, Christian (Author) , Hensel, Manfred (Author) , Seidel-Glätzer, Andrea (Author) , Weisel, Katja (Author) , Salwender, Hans (Author) , Müller-Tidow, Carsten (Author) , Raab, Marc-Steffen (Author) , Goldschmidt, Hartmut (Author) , Mai, Elias K. (Author) , Hundemer, Michael (Author) ,


    Get full text
    Article (Journal) Online Resource